ATOSSA THERAPEUTICS, INC. (ATOS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 250K 500K 750K FY11: 1.5K FY12: 481.8K FY13: 632.6K FY14: 40.1K FY15: 1.8K FY11 FY12 FY13 FY14 FY15

Gross Profit Annual

-150K 0 150K 300K 450K FY11: -95.7K FY12: 416.2K FY13: 137.1K FY14: 40.1K FY15: -130.7K FY11 FY12 FY13 FY14 FY15

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY11: -3.4M FY12: -5.1M FY13: -10.8M FY14: -12.2M FY15: -12.8M FY16: -8M FY17: -7.6M FY18: -11.4M FY19: -17.3M FY20: -14.6M FY21: -20.5M FY22: -27.7M FY23: -31.4M FY24: -27.6M FY25: -37.1M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY10: -1.1M FY11: -3.4M FY12: -5.1M FY13: -10.8M FY14: -14.7M FY15: -15.8M FY16: -6.4M FY17: -8.1M FY18: -11.4M FY19: -17.2M FY20: -17.8M FY21: -20.6M FY22: -27M FY23: -30.1M FY24: -25.5M FY25: -34.8M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 150K 300K 450K FY11: 5.2K FY12: 35.7K FY13: 345.5K FY14: 0 FY15: 132.4K FY11 FY12 FY13 FY14 FY15

Operating Cash Flow Annual

-30M -15M 0 15M 30M 45M FY11: -3.5M FY12: -3.9M FY13: -8.8M FY14: -10.6M FY15: -14M FY16: -5.4M FY17: -6.6M FY18: -9M FY19: -9.1M FY20: -11.6M FY21: -16.5M FY22: -20.8M FY23: -20.9M FY24: -21M FY25: -29.8M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-30M -15M 0 15M 30M 45M FY18: -9.1M FY19: -9.1M FY20: -11.6M FY21: -16.5M FY22: -20.8M FY23: -21M FY24: -21M FY25: -29.8M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 50M 100M 150M FY21: 117M FY22: 126.6M FY23: 126.1M FY24: 8.4M FY25: 8.6M FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q2 '12: -0.41 Q3 '12: -0.40 Q4 '12: -0.40 Q1 '13: -0.45 Q2 '13: -0.52 Q3 '13: -0.64 Q4 '13: -0.68 Q1 '14: -0.64 Q2 '14: -0.60 Q3 '14: -0.51 Q4 '14: -0.60 Q1 '15: -0.63 Q2 '15: -0.61 Q3 '15: -0.63 Q4 '15: -8.31 Q1 '16: -9.16 Q2 '16: -9.72 Q3 '16: -9.50 Q4 '16: -2.30 Q1 '17: -6.72 Q2 '17: -13.77 Q3 '17: -15.95 Q4 '17: -10.97 Q1 '18: -14.05 Q2 '18: -11.41 Q3 '18: -9.94 Q4 '18: -5.50 Q1 '19: 2.36 Q2 '19: 6.64 Q3 '19: 6.92 Q4 '19: -2.04 Q1 '20: -1.74 Q2 '20: -1.37 Q3 '20: -1.35 Q4 '20: -1.97 Q1 '21: -1.69 Q2 '21: -1.32 Q3 '21: -1.02 Q4 '21: -0.18 Q1 '22: -0.18 Q2 '22: -0.17 Q3 '22: -0.19 Q4 '22: -0.21 Q1 '23: -0.22 Q2 '23: -0.25 Q3 '23: -0.24 Q4 '23: -0.24 Q1 '24: -0.24 Q2 '24: -0.21 Q3 '24: -0.22 Q4 '24: -3.05 Q1 '25: -3.78 Q2 '25: -4.71 Q3 '25: -4.72 Q4 '25: -5.69 Q1 '26: -6.02 Q2 '26: -5.99 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.